Exhibitors Profiles

Cobra Biologics

Expertise
Cobra Biologics is a Contract Manufacturing Organisation supporting the global life sciences industry in the development and manufacture of monoclonal antibodies, recombinant proteins, DNA, viruses and cell line derived products and pharmaceuticals for clinical trials and commercial supply.

Experience
Over 14 years of track record in producing biologics and pharmaceuticals for use in pre-clinical to Phase III clinical trials and commercial supply has given Cobra Biologics’ people a unique knowledge base as both manufacturer and also as service providers for the global life sciences market.

Excellence
Every program complies with cGMP standards worldwide and is conceived with an unmatched quality derived from the know-how of its highly qualified, flexible and dedicated people.

Cobra Biologics has three GMP approved facilities. The Matfors facility is 15km from Sundsvall in Sweden. Our second site in Sweden, the Södertälje facility, is located 30km south of Stockholm, and is in the centre of the major Scandinavian biomanufacuturing hub. Our third site, the Keele facility, is located in the UK and is only 40km south of Manchester Airport. All sites offer a comprehensive service to take your project from conception to fill and finish.

We offer a broad range of integrated and stand-alone development services, stretching from cell line development to the supply of investigational medicinal product and market supply.

We take pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.

www.cobrabio.com

DSM Biologics

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.

DSM’s 22,000 employees deliver annual net sales of about €9 billion. The company is listed on NYSE Euronext.

www.dsm.com

United Technologies UT

United Technologies UT AG was founded in 2007. The company is incorporated in Zurich, Switzerland, with the purpose to develop biotechnological skin care products for cosmetic and pharmaceutical applications.

United Technologies UT employs an international scientific team driven by the passion to develop highly innovative and effective products based on a deep understanding of the biology of skin and hair, their age-associated changes and repair mechanisms.

The main assets of United Technologies UT are Dermatopoietin and Hexadeltine, two peptides with proven efficacy for dermal regeneration and replenishment of collagen in skin. Applications are in dermatocosmetics and dermatology (difficult-to-heal wounds).

For production and distribution United Technologies UT cooperates with partner companies in Switzerland and abroad.

United Technologies UT AG has filed several patents around the globe to protect its intellectual property rights in the field of cosmetics, dermatology and oral health.

www.unitech.ch